Clinical Trials Browser

Cystitis, Hemorrhagic, Urinary Bladder Diseases, Urinary Bladder Neoplasms, Urinary Bladder, Neurogenic, Endometriosis, Cystitis, Interstitial, Malnutrition

NCT06525571 2025-11-18

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

Phase 3 Recruiting

200 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT07067749 2025-07-24

TEMPO-MIBC

Phase 3 Recruiting

92 enrolled

Genitourinary

Urinary Bladder Neoplasms, Neoplasms

NCT04574960 2025-07-20

NAUTICAL

Phase 3 Recruiting

14 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT06441110 2024-06-04

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Phase 3 Recruiting

76 enrolled

Genitourinary

Urinary Bladder Neoplasms, Motor Activity, Neoplasm Recurrence, Local

NCT06241755 2024-02-05

Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Phase 3 Recruiting

412 enrolled

Genitourinary

Non-Muscle Invasive Bladder Neoplasms, Urinary Bladder Neoplasms

NCT03216525 2023-09-28

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

Phase 3 Recruiting

136 enrolled

Genitourinary

Urinary Bladder Neoplasms

NCT04947059 2022-01-26

GENSA

Phase 3 Recruiting

180 enrolled

Genitourinary

Urinary Bladder Neoplasms

Clinical Trials

TroFuse-031

Testing Shorter Duration Radiation Therapy Versus the Usual Radiation Therapy in Patients Receiving the Usual Chemotherapy Treatment for Bladder Cancer, ARCHER Study

GAIN-BCG

Perioperative Durvalumab With Neoadjuvant ddMVAC or Gemcitabine/Cisplatin in Patients With Muscle-invasive Bladder Cancer (NIAGARA-2)

EVER

FORAGER-2

A Study of Surgical Techniques During Cystectomy

BCG for Therapeutic Use Phase Ⅲ Clinical Trial

INCyst

Outcomes of High-risk Non-muscle Invasive Bladder Cancer Treated With Blue Light Resection

TEMPO-MIBC

NAUTICAL

Multicenter Clinical Trial on the Effectiveness and Safety of Instillation of BCG and Alternative BCG Protocols for Intermediate and High-risk Non-muscle Invasive Bladder Cancer

Clinical Trial for Evaluating the Efficacy and Safety of BCG for Therapeutic Use in the Prevention of Postoperative Recurrence of Medium/High-risk Non-muscle Invasive Bladder Cancer (NMIBC)

Alvimopan Versus Placebo in Patients Undergoing Radical Cystectomy on an Enhanced Recovery Protocol

GENSA